Clinical Omics – Products

The Vivid plasma separation membrane utilizes a patented process where highly asymmetric membranes are specifically engineered for the generation of plasma from whole blood.

Bruker’s majority investment in RECIPE enhances clinical diagnostics with advanced drug monitoring solutions and high-throughput, chromatography-free technologies.

PacBio (NASDAQ: PACB), announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics.

Azenta, Inc. (Nasdaq: AZTA) announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications.

Thermo Fisher Scientific has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients eligible for treatment with Servier Pharmaceuticals.

Eremid® Genomic Services Partners With Semaphore Solutions To Implement Cutting-Edge Labbit LIMS.

Consortium aims to share best practices and increase our understanding of genetic disease.

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States.

A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.

Combined with the Ion Torrent Genexus Integrated Sequencer, new assays deliver valuable genomic insights in the field of aneuploidy analysis.